The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles.
biomarkers
controlled ovarian stimulation
in vitro fertilization
ovarian responsiveness
ovarian sensitivity index
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
18 Jun 2020
18 Jun 2020
Historique:
received:
16
04
2020
revised:
10
06
2020
accepted:
15
06
2020
entrez:
24
6
2020
pubmed:
24
6
2020
medline:
24
6
2020
Statut:
epublish
Résumé
Some biomarkers of ovarian responsiveness to gonadotropins and the total number of retrieved oocytes are known to affect the success rate after controlled ovarian stimulation (COS) and in vitro fertilization (IVF). The aim of this study was to study another putative marker, the Ovarian Sensitivity Index (OSI: (number of retrieved oocytes/total gonadotropin dose) × 1000), assessing whether (a) it correlates with ovarian responsiveness biomarkers, (b) it is an independent predictor of clinical pregnancy, (c) it predicts clinical pregnancy comparably to the number of retrieved oocytes, and (d) it is consistent in the repeated COS cycles of the same woman. retrospective analysis. public IVF Unit in University Hospital. Cases and Measurements: 1612 patients submitted to 3353 IVF cycles were included, their OSI was calculated and it was correlated with the ovarian responsiveness biomarkers (age, BMI, anti-Mullerian hormone, antral follicle count). The OSI and the total number of oocytes were compared for their value in predicting clinical pregnancy. The inter-cycle consistency of the OSI was estimated in 209 patients who underwent two consecutive cycles in which the ovarian stimulation regimen was changed from the Gonadotropin-releasing Hormone (GnRH)-agonist long protocol to the GnRH-antagonist protocol or vice-versa. The OSI turned out to be significantly related to age and BMI (inversely), the anti-Mullerian hormone (AMH) and the antral follicle count (AFC) (directly), to be an independent predictor of clinical pregnancy, and to correlate with clinical pregnancy better than the total number of oocytes ( The OSI significantly correlates to the currently used biomarkers of ovarian responsiveness; it is an independent predictor of clinical pregnancy; it is more predictive of clinical pregnancy than the total number of oocytes, and is highly consistent in repeated IVF cycles even when the COS protocol changes. These characteristics make the OSI quite suitable to be incorporated into more complex prediction models of IVF outcome.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Some biomarkers of ovarian responsiveness to gonadotropins and the total number of retrieved oocytes are known to affect the success rate after controlled ovarian stimulation (COS) and in vitro fertilization (IVF). The aim of this study was to study another putative marker, the Ovarian Sensitivity Index (OSI: (number of retrieved oocytes/total gonadotropin dose) × 1000), assessing whether (a) it correlates with ovarian responsiveness biomarkers, (b) it is an independent predictor of clinical pregnancy, (c) it predicts clinical pregnancy comparably to the number of retrieved oocytes, and (d) it is consistent in the repeated COS cycles of the same woman.
DESIGN
METHODS
retrospective analysis.
SETTING
METHODS
public IVF Unit in University Hospital. Cases and Measurements: 1612 patients submitted to 3353 IVF cycles were included, their OSI was calculated and it was correlated with the ovarian responsiveness biomarkers (age, BMI, anti-Mullerian hormone, antral follicle count). The OSI and the total number of oocytes were compared for their value in predicting clinical pregnancy. The inter-cycle consistency of the OSI was estimated in 209 patients who underwent two consecutive cycles in which the ovarian stimulation regimen was changed from the Gonadotropin-releasing Hormone (GnRH)-agonist long protocol to the GnRH-antagonist protocol or vice-versa.
RESULTS
RESULTS
The OSI turned out to be significantly related to age and BMI (inversely), the anti-Mullerian hormone (AMH) and the antral follicle count (AFC) (directly), to be an independent predictor of clinical pregnancy, and to correlate with clinical pregnancy better than the total number of oocytes (
CONCLUSION(S)
CONCLUSIONS
The OSI significantly correlates to the currently used biomarkers of ovarian responsiveness; it is an independent predictor of clinical pregnancy; it is more predictive of clinical pregnancy than the total number of oocytes, and is highly consistent in repeated IVF cycles even when the COS protocol changes. These characteristics make the OSI quite suitable to be incorporated into more complex prediction models of IVF outcome.
Identifiants
pubmed: 32570935
pii: jcm9061914
doi: 10.3390/jcm9061914
pmc: PMC7355532
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2013 Apr 23;8(4):e61095
pubmed: 23637787
Fertil Steril. 2017 Mar;107(3):641-648.e2
pubmed: 28108009
Hum Reprod. 2011 Feb;26(2):414-22
pubmed: 21147822
J Assist Reprod Genet. 2014 Feb;31(2):199-203
pubmed: 24317853
Fertil Steril. 2013 Nov;100(5):1270-6
pubmed: 23931964
Biol Reprod. 2003 Sep;69(3):1023-31
pubmed: 12748128
Hum Reprod Update. 2008 Jan-Feb;14(1):1-14
pubmed: 18006561
Reprod Biol Endocrinol. 2011 Aug 09;9:112
pubmed: 21824441
Hum Reprod. 2007 Feb;22(2):548-57
pubmed: 17095516
Hum Reprod Update. 2006 Nov-Dec;12(6):685-718
pubmed: 16891297
Hum Reprod. 2013 Feb;28(2):442-52
pubmed: 23136144
Hum Reprod. 2012 Apr;27(4):1066-72
pubmed: 22279090
Hum Reprod. 2011 Jul;26(7):1768-74
pubmed: 21558332
Front Endocrinol (Lausanne). 2018 Oct 17;9:589
pubmed: 30386293
Fertil Steril. 2013 Mar 15;99(4):970-8.e1
pubmed: 23380184
Ultrasound Obstet Gynecol. 2016 Sep;48(3):289-95
pubmed: 26924732